Kaleido Competitors

Delisted . USA . 
Stock . Kaleido Biosciences
KLDODelisted Stock  USD 0.01  0.00  0.00%   
Kaleido Biosciences competes with Inhibikase Therapeutics, Tempest Therapeutics, CytomX Therapeutics, Assembly Biosciences, and Instil Bio; as well as few others. The company conducts business under Pharmaceuticals sector and is part of Health Care industry. Analyzing Kaleido Biosciences competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Kaleido Biosciences to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Kaleido Biosciences competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Kaleido Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.010.010.01
Details
Intrinsic
Valuation
LowRealHigh
0.010.010.01
Details
Naive
Forecast
LowNextHigh
0.010.010.01
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-0.003500.01
Details

Kaleido Biosciences Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Kaleido Biosciences and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Kaleido and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Kaleido Biosciences does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
TPST
+ 0.83
SIOX
CTMX
+ 0.83
TPST
EMMA
+ 0.72
TPST
CTMX
+ 0.69
SIOX
EMMA
+ 0.65
SIOX
EMMA
+ 0.64
CTMX
  
High negative correlations   
SIOX
- 0.85
IKT
TPST
- 0.77
IKT
EMMA
- 0.7
IKT
CTMX
- 0.68
IKT
TIL
- 0.34
IKT
NLTX
- 0.31
IKT

Risk-Adjusted Indicators

There is a big difference between Kaleido Pink Sheet performing well and Kaleido Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Kaleido Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
GLSH  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
IKT  4.43  0.51  0.10  0.39  5.31 
(5.12)
 13.22 
(9.09)
 37.40 
SIOX  1.07 (0.05) 0.00  0.21  0.00 
 0.00 
 2.33 
(2.38)
 11.21 
TPST  3.86 (0.75) 0.00 (0.59) 0.00 
 0.00 
 6.38 
(8.53)
 29.55 
NLTX  2.25 (0.19) 0.00 (1.83) 0.00 
 0.00 
 4.05 
(3.53)
 27.84 
CTMX  2.62 (0.64) 0.00 (0.45) 0.00 
 0.00 
 5.00 
(5.49)
 20.61 
ASMB  2.91  0.04  0.00  0.19  4.40 
(2.83)
 8.49 
(5.34)
 24.80 
TIL  9.39  1.56  0.25  0.40  6.84 
(12.92)
 20.63 
(10.89)
 105.83 
NUVB  3.71 (0.33)(0.01) 0.01  4.53 
(4.01)
 9.48 
(8.36)
 21.30 
EMMA  6.43  0.20  0.00 (0.05) 7.45 
(11.24)
 18.52 
(13.33)
 45.86 
All Fundamental Data

Kaleido Biosciences Competitive Analysis

The better you understand Kaleido Biosciences competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Kaleido Biosciences' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Kaleido Biosciences' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
KLDO IKT SIOX TPST NLTX CTMX ASMB TIL NUVB EMMA
 0.00 
 0.01 
Kaleido
 14.93 
 2.31 
Inhibikase
 2.56 
 0.40 
Sio
 2.25 
 0.91 
Tempest
 1.43 
 0.69 
Neoleukin
 2.30 
 0.89 
CytomX
 2.17 
 15.04 
Assembly
 5.61 
 26.15 
Instil
 3.70 
 2.80 
Nuvation
 0.00 
 0.26 
Emmaus
Market Volatility
(90 Days Market Risk)
Very steady
Moderately volatile
Very steady
Relatively risky
Very steady
Dangerous
Relatively risky
Unstable
Very risky
Very steady
Market Performance
(90 Days Performance)
Very Weak
Good
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
OK
Very Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Below Average
Dangerous
Very High
Dangerous
Above Average
Low
Average
About Average
Dangerous
Current Valuation
(Equity Enterprise Value)
Over Valued
Under Valued
Over Valued
Under Valued
Over Valued
Under Valued
Over Valued
Over Valued
Under Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Buy
Not Available
Strong Buy
Not Available
Buy
Strong Buy
Buy
Strong Buy
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Sell
Not Rated
Strong Sell
Not Rated
Strong Sell
Strong Sell
Hold
Strong Sell
Not Rated
Current Ratio
1.42
7.56
6.46
3.05
12.78
2.05
8.31
8.51
33.58
0.14
Net Asset
50.14 M
14.51 M
75.08 M
51.6 M
115.95 M
201.79 M
137.47 M
325.63 M
621.48 M
56.73 M
Profit Margin
N/A
N/A
N/A
N/A
N/A
0.11
-2.12
N/A
N/A
-1.14
EBITDA
(85.09 M)
(19.91 M)
(70.94 M)
(28.78 M)
(56.48 M)
(4.31 M)
(64.2 M)
(146.12 M)
(99.6 M)
(12.76 M)
Operating Margin
-79.28
-238.85
N/A
N/A
N/A
0.12
-1.43
N/A
-66.16
-0.65
Current Valuation
(16.73 M)
131.96 M
(23.36 M)
34.62 M
(35.02 M)
(39.18 M)
52.53 K
126.57 M
370.79 M
49.41 M
Price To Book
0.0044
26.46
0.54
3.4
0.44
5.04
3.6
0.92
1.81
N/A
Retained Earnings
(197.63 M)
(66.9 M)
N/A
(165.26 M)
(451.06 M)
(723.45 M)
(785.75 M)
(580.98 M)
(342.8 M)
(82.78 M)
Current Asset
72.93 M
N/A
N/A
N/A
289 K
189.75 M
68.37 M
N/A
N/A
9.19 M
Beta
0.42
1.12
1.49
-2.78
1.1
1.06
0.59
1.74
1.36
1.97
Number Of Employees
76
8
12
17
7
120
65
49
203
58
Shares Outstanding
42.62 M
67.19 M
73.98 M
43.64 M
2.35 M
78.26 M
6.36 M
6.53 M
335.57 M
49.56 M
Cash Flow From Operations
(77.09 M)
(18.09 M)
(60.35 M)
(27.36 M)
(45.61 M)
(56.03 M)
22.74 M
(82.03 M)
(68 M)
(1.25 M)
Total Debt
5.55 M
622 K
2.36 M
20.66 M
12.07 M
13.97 M
2.34 M
86.05 M
4.01 M
4.65 M
Return On Equity
-5.81
-1.5
-0.47
-2.89
-0.38
-54.75
-1.02
-0.49
-0.96
N/A
Z Score
-6.3
N/A
7.2
N/A
-5.73
N/A
N/A
N/A
N/A
1.6
Return On Asset
-1.0
-0.76
-0.24
-0.54
-0.19
0.0233
-0.35
-0.12
-0.14
-0.12
Number Of Shares Shorted
2.34 M
187.95 K
71.39 K
2.64 M
26.4 K
5.67 M
7.95 K
376 K
11.32 M
41.22 K
Book Value Per Share
0.25
1.78
0.61
1.21
34.18
-0.3
7.5
34.72
1.5
-0.76
Current Liabilities
10.39 M
N/A
N/A
N/A
1.02 M
15.74 M
3.4 M
N/A
N/A
7.25 M
Total Asset
50.14 M
14.51 M
75.08 M
51.6 M
115.95 M
201.79 M
137.47 M
325.63 M
621.48 M
56.73 M
Debt To Equity
2.05
0.006
0.045
0.49
0.11
0.67
0.041
0.12
0.006
-0.041
Short Ratio
29.34
0.17
0.11
0.39
1.7
9.58
0.41
2.29
7.28
0.48
Target Price
22.0
7.0
5.0
18.75
1.5
5.29
35.5
100.33
6.5
4.0
Shares Owned By Institutions
0.36
11.62
26.82
23.02
45.58
65.31
18.79
80.7
56.3
N/A
Market Capitalization
421.96 K
135.06 M
30.63 M
39 M
8.2 M
67.81 M
93.56 M
161.58 M
908.73 M
24.28 M
Price To Earning
-1.45
N/A
N/A
0.23
-4.6
-11.41
-10.58
18.31
N/A
-1.6
Price To Earnings To Growth
N/A
N/A
N/A
N/A
-0.03
-1.8
N/A
N/A
N/A
N/A
Price To Sales
0.0425
1697.34
N/A
N/A
N/A
0.54
4.36
55329.79
420.32
1.06
Net Income
(90.29 M)
(19.03 M)
(71.89 M)
(29.49 M)
(57.56 M)
(569 K)
(61.23 M)
(156.09 M)
(75.8 M)
(15.95 M)
Earnings Per Share
-2.16
-3.12
-0.38
-1.53
-12.28
0.16
-6.89
-11.56
-2.18
-0.18
Shares Owned By Insiders
0.73
10.46
25.3
0.24
16.46
1.0
31.62
12.86
26.85
38.73
Revenue
1.1 M
260.5 K
N/A
N/A
N/A
101.21 M
7.16 M
N/A
N/A
20.61 M
Working Capital
62.54 M
10.77 M
N/A
30.95 M
88.07 M
27.02 M
94.56 M
150.2 M
602.46 M
1.95 M
Cash And Equivalents
38.47 M
32.21 M
54.77 M
51.62 M
116.46 M
194.29 M
116.69 M
354.61 M
703.8 M
982 K
Cash Per Share
0.9
1.28
0.74
4.95
2.73
2.94
2.41
2.73
3.22
0.02
Gross Profit
(66.7 M)
(8.26 M)
N/A
N/A
N/A
53.16 M
(63.9 M)
138 K
N/A
17.3 M
Day Typical Price
0.01
2.22
0.4
0.9
0.69
0.88
14.9
25.67
2.76
0.26
Accumulation Distribution
N/A
35848.33
0.0714
48012.13
0.0563
21998.13
1399.0
9126.72
183232.0
N/A
Market Facilitation Index
N/A
0.0
0.03
N/A
0.04
N/A
0.0
0.0
N/A
N/A
Daily Balance Of Power
0.0
0.6977
0.3333
0.3333
(0.25)
0.5
0.4267
0.5187
0.6667
0.0
Period Momentum Indicator
N/A
0.3
0.01
0.02
(0.01)
0.02
0.32
1.39
0.1
N/A
Rate Of Daily Change
1.0
1.15
1.03
1.02
0.99
1.02
1.02
1.06
1.04
1.0
Day Median Price
0.01
2.17
0.41
0.9
0.69
0.88
14.83
25.43
2.74
0.26
Price Action Indicator
N/A
0.29
N/A
0.02
(0.01)
0.02
0.37
1.41
0.11
N/A
Coefficient Of Variation
774.43
916.71
(2,064)
(803.57)
(2,179)
(685.44)
4421.11
765.82
8019.07
12169.09
Mean Deviation
154.54
4.43
1.07
3.86
2.25
2.62
2.91
9.39
3.71
6.43
Jensen Alpha
84.32
0.5066
(0.05)
(0.75)
(0.19)
(0.64)
0.0398
1.56
(0.33)
0.2039
Total Risk Alpha
(0.81)
(0.14)
(0.35)
(1.31)
(0.66)
(0.98)
(0.46)
(0.01)
(0.58)
(1.17)
Sortino Ratio
N/A
0.1043
N/A
N/A
N/A
N/A
(0)
0.2538
(0.01)
(0)
Downside Variance
N/A
30.78
N/A
N/A
N/A
N/A
20.12
60.79
22.53
121.9
Standard Deviation
616.13
6.31
1.89
5.1
3.7
3.51
4.17
15.99
4.86
9.51
Kurtosis
61.85
1.85
6.73
1.66
13.95
1.81
3.5
11.81
0.2169
0.9367
Potential Upside
50.0
13.22
2.33
6.38
4.05
5.0
8.49
20.63
9.48
18.52
Treynor Ratio
(1.66)
0.3933
0.2076
(0.59)
(1.83)
(0.45)
0.1885
0.4014
0.0131
(0.05)
Maximum Drawdown
4848.99
37.4
11.21
29.55
27.84
20.61
24.8
105.83
21.3
45.86
Variance
379616.71
39.78
3.57
26.04
13.69
12.29
17.36
255.78
23.64
90.5
Market Risk Adjusted Performance
(1.65)
0.4033
0.2176
(0.58)
(1.82)
(0.44)
0.1985
0.4114
0.0231
(0.04)
Risk Adjusted Performance
0.1085
0.092
(0.03)
(0.09)
(0.03)
(0.10)
0.0254
0.1091
0.0179
0.0155
Skewness
7.86
0.5135
(1.80)
(0.64)
(2.77)
0.6961
(0.51)
3.03
0.2642
0.462
Semi Deviation
N/A
5.31
N/A
N/A
N/A
N/A
4.4
6.84
4.53
7.45
Information Ratio
0.1289
0.0917
(0.11)
(0.15)
(0.08)
(0.18)
(0)
0.1237
(0.01)
(0)
Value At Risk
N/A
(9.09)
(2.38)
(8.53)
(3.53)
(5.49)
(5.34)
(10.89)
(8.36)
(13.33)
Expected Short fall
N/A
(5.12)
N/A
N/A
N/A
N/A
(2.83)
(12.92)
(4.01)
(11.24)
Downside Deviation
N/A
5.55
N/A
N/A
N/A
N/A
4.49
7.8
4.75
11.04
Semi Variance
N/A
28.14
N/A
N/A
N/A
N/A
19.35
46.83
20.48
55.57

Kaleido Biosciences Competition Performance Charts

Five steps to successful analysis of Kaleido Biosciences Competition

Kaleido Biosciences' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Kaleido Biosciences in relation to its competition. Kaleido Biosciences' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Kaleido Biosciences in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Kaleido Biosciences' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Kaleido Biosciences, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Kaleido Biosciences position

In addition to having Kaleido Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Computers Thematic Idea Now

Computers
Computers Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Computers theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Computers Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Consideration for investing in Kaleido Pink Sheet

If you are still planning to invest in Kaleido Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kaleido Biosciences' history and understand the potential risks before investing.
Global Correlations
Find global opportunities by holding instruments from different markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY